Inorganics (Apr 2023)

Novel Copper(II) Complexes with <i>N</i><sup>4</sup>,<i>S</i>-Diallylisothiosemicarbazones as Potential Antibacterial/Anticancer Drugs

  • Vasilii Graur,
  • Irina Usataia,
  • Ianina Graur,
  • Olga Garbuz,
  • Paulina Bourosh,
  • Victor Kravtsov,
  • Carolina Lozan-Tirsu,
  • Greta Balan,
  • Valeriu Fala,
  • Aurelian Gulea

DOI
https://doi.org/10.3390/inorganics11050195
Journal volume & issue
Vol. 11, no. 5
p. 195

Abstract

Read online

The six new copper(II) coordination compounds [Cu(HL1)Cl2] (1), [Cu(HL1)Br2] (2), [Cu(H2O)(L1)(CH3COO)]·1.75H2O (3), [Cu(HL2)Cl2] (4), [Cu(HL2)Br2] (5), [Cu(H2O)(L2)(CH3COO)] (6) were synthesized with 2-formyl- and 2-acetylpyridine N4,S-diallylisothiosemicarbazones (HL1 and HL2). The new isothiosemicarbazones were characterized by NMR, FTIR spectroscopy, and X-ray crystallography ([H2L2]I). All copper(II) coordination compounds were characterized by elemental analysis, FTIR spectroscopy, and molar conductivity of their 1mM methanol solutions. Furthermore, the crystal structure of complex 3 was determined using single-crystal X-ray diffraction analysis. The studied complexes manifest antibacterial and antifungal activities, that in many cases are close to the activity of medical drugs used in this area, and in some cases even exceed them. The complexes 4 and 5 showed the highest indexes of selectivity (280 and 154) and high antiproliferative activity against BxPC-3 cell lines that surpass the activity of Doxorubicin. The complexes 1–3 also manifest antioxidant activities against cation radicals ABTS•+ that are close to that of trolox, the antioxidant agent used in medicine.

Keywords